Xiamen, China

Qing Luo

This inventor holds 1 USPTO granted patent. Top assignee: Xiamen LP Pharmaceutical Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qing Luo. Retrieved from https://idiyas.com/inventor/qing-luo-izt01p1s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qing Luo - Innovator in Pharmaceutical Delivery Systems

Introduction

Qing Luo is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceutical compositions, particularly in the delivery of medications through innovative methods.

Latest Patents

Qing Luo holds a patent for a palonosetron oral transmucosal film or patch. This invention provides a pharmaceutical composition designed for delivering palonosetron through the buccal mucosa or sublingual mucosa. The composition includes 0.05-35% (w/w) of palonosetron, 40-90% of a film-forming agent, 1-10% (w/w) of a plasticizer, 5-25% (w/v) of an adhesive agent, and 0.1-5% of a penetration-enhancing agent. Preferred components include polysorbate as a plasticizer, polyvinylpyrrolidone or carboxymethylcellulose as an adhesive agent, and peppermint oil or menthol as a penetration-enhancing agent.

Career Highlights

Qing Luo is currently associated with Xiamen LP Pharmaceutical Co., Ltd. His work focuses on developing advanced pharmaceutical delivery systems that enhance the efficacy of medications.

Collaborations

He collaborates with notable colleagues, including Haijian Zhu and Rongbin Ling, who contribute to his innovative projects.

Conclusion

Qing Luo's work in pharmaceutical compositions exemplifies the importance of innovation in improving drug delivery methods. His contributions are paving the way for more effective treatments in the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…